Range Low Price High Price Comment
30 days $0.256 $1.99 Friday, 24th May 2024 GLYC stock ended at $0.270. This is 1.17% less than the trading day before Thursday, 23rd May 2024. During the day the stock fluctuated 6.71% from a day low at $0.264 to a day high of $0.282.
90 days $0.256 $3.18
52 weeks $0.256 $3.53

Historical GlycoMimetics prices

Date Open High Low Close Volume
Mar 24, 2020 $2.22 $2.39 $2.14 $2.23 677 188
Mar 23, 2020 $2.08 $2.43 $2.01 $2.15 1 869 175
Mar 20, 2020 $2.01 $2.16 $1.96 $2.08 613 149
Mar 19, 2020 $1.88 $2.01 $1.88 $2.00 444 843
Mar 18, 2020 $2.10 $2.17 $1.82 $1.83 258 707
Mar 17, 2020 $1.97 $2.22 $1.94 $2.21 494 070
Mar 16, 2020 $1.90 $2.38 $1.85 $1.92 556 473
Mar 13, 2020 $2.75 $2.87 $2.45 $2.54 298 378
Mar 12, 2020 $2.75 $2.87 $2.62 $2.65 155 947
Mar 11, 2020 $3.10 $3.17 $2.93 $2.94 219 327
Mar 10, 2020 $3.28 $3.44 $3.05 $3.10 239 195
Mar 09, 2020 $3.34 $3.43 $3.04 $3.22 266 415
Mar 06, 2020 $3.39 $3.51 $3.39 $3.47 127 414
Mar 05, 2020 $3.40 $3.51 $3.40 $3.49 169 204
Mar 04, 2020 $3.60 $3.60 $3.44 $3.50 340 556
Mar 03, 2020 $3.52 $3.61 $3.36 $3.47 278 310
Mar 02, 2020 $3.47 $3.59 $3.40 $3.51 222 233
Feb 28, 2020 $3.34 $3.81 $3.12 $3.61 261 014
Feb 27, 2020 $3.57 $3.71 $3.46 $3.49 219 205
Feb 26, 2020 $3.77 $3.82 $3.56 $3.66 230 796
Feb 25, 2020 $3.99 $3.99 $3.75 $3.77 113 574
Feb 24, 2020 $4.02 $4.12 $3.88 $3.97 124 258
Feb 21, 2020 $4.20 $4.21 $4.08 $4.10 123 013
Feb 20, 2020 $4.21 $4.28 $4.09 $4.21 98 279
Feb 19, 2020 $4.32 $4.34 $4.22 $4.23 110 939

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use GLYC stock historical prices to predict future price movements?
Trend Analysis: Examine the GLYC stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the GLYC stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About GlycoMimetics

GlycoMimetics GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT